Category
Primary
pharmaceutical-drugs · embed-ft 0.23
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
CMS
Analytics
CDN
Consent/CMP
AI readiness
Compliance (GEO / GDPR)
TLD
Overview
Title
Esperoct® [antihemophilic factor (recombinant), glycopegylated-exei] HCP Site
Description
Esperoct® is approved for routine prophylaxis, on-demand treatment, and perioperative management in children, adolescents, and adults with Hemophilia A. Read important safety & prescribing info on this page.
Final URL
Language
en (html)
Scanned at
2026-06-21 19:34:36